Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
Saved in:
| Title: | Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors. |
|---|---|
| Authors: | Chawla, Neal S.1, Sayegh, Nicolas2, Tripathi, Nishita2 atripathi@coh.org, Govindarajan, Ameish1, Zengin, Zeynep B.1, Phillip, Errol J.3, Dizman, Nazli4, Meza, Luis1, Muddasani, Ramya1, Chehrazi-Raffle, Alexander1, Malhotra, Jasnoor1, Hsu, JoAnn1, Agarwal, Neeraj2, Pal, Sumanta K.1, Tripathi, Abhishek1 |
| Source: | Clinical Genitourinary Cancer. Feb2023, Vol. 21 Issue 1, p69-75. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
